Business Description
GlucoTrack Inc
NAICS : 339112
SIC : 3841
ISIN : US45824Q8042
Total Employee Number:
15Description
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.1 | |||||
Equity-to-Asset | -0.2 | |||||
Debt-to-Equity | -4.22 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 74 | |||||
3-Year EPS without NRI Growth Rate | 75.4 | |||||
3-Year FCF Growth Rate | 72.9 | |||||
3-Year Book Growth Rate | -80.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.36 | |||||
9-Day RSI | 22.17 | |||||
14-Day RSI | 28.5 | |||||
3-1 Month Momentum % | -53.27 | |||||
6-1 Month Momentum % | -88.86 | |||||
12-1 Month Momentum % | -91.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -572.1 | |||||
Shareholder Yield % | -425.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -447.6 | |||||
ROA % | -209.51 | |||||
ROIC % | -683.5 | |||||
3-Year ROIIC % | -361.26 | |||||
ROC (Joel Greenblatt) % | -10807.59 | |||||
ROCE % | -415.18 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.11 | |||||
EV-to-EBITDA | -0.11 | |||||
EV-to-FCF | -0.11 | |||||
Earnings Yield (Greenblatt) % | -909.09 | |||||
FCF Yield % | -749.82 |
GF Valueâ„¢
GlucoTrack Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlucoTrack Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 141 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 50 days | ||
| General meeting for 2025 | 2026-06-24 12:00 | 0.36 (-5.23%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.70 (-2.78%) | ||
| Annual report for 2025 | 2026-03-30 | 0.99 (-28.25%) | ||
| Fourth quarter earnings results for 2026 | 2026-03-30 | 0.99 (-28.25%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 5.93 (+4.50%) | ||
| Q3 Virtual Investor Summit | 2025-09-16 13:30 | 7.78 (-10.47%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 5.80 (+0.87%) | ||
| 0.0166667:1 Stock Split | 2025-06-16 | 5.69 (-10.39%) |
Show
Entries
Guru Commentaries on NAS:GCTK
No articles.
Press Release
Articles on GlucoTrack Inc
No articles.